🐦 推特ZeroHedgeCodex · 实盘可交易 · 做空市场:美股▲ 赚 +3.67% · 已结算把握 6/10
北京时间·🕒 发布 20:27:40时区推断·⟳ 抓取 20:27:58·⚡ 决策 09-08 21:43:41 +1h15m·48.7 天前
Boston Scientific披露网络攻击将实质影响三季度及2026全年业绩指引
BSX.US存在一手SEC披露、盘中可成交、方向明确的直接经营与指引利空，虽缺口未量化且已有盘前反应，但仍满足中等置信的短线做空条件。
📄 原文ZeroHedge@zerohedge↗ 原文
Premarket movers: Mag 7 stocks are mostly lower: Nvidia +0.3%, Tesla +0.2%, Alphabet -0.7%, Apple -0.4%, Amazon -0.9%,…
▲ 赚 +3.67%入场 09-08 盘前首笔 @46.98 → 离场 09-09 常规开盘 @45.10
日 K 取自复盘打分切片 · 蓝点/蓝虚线 = 纸面入场价 · 灰虚线 = 纸面离场 · 持有期红底 = 赚(做空:价格在入场线下方)、绿底 = 亏
💡 交易逻辑网络攻击致全年指引受损，盘中仍可重估
怎么做空 立刻做空 不设价格下限（市价成交）
怎么平空 止盈 -4%(半仓)/-8%(清仓) · 止损 +4% · 时间止损 5日
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
分时走势
做空 BSX.US Boston Scientific Corporation
建仓日早于近 30 天,只有日线图
成交明细 · 纸面
做空 BSX.US Boston Scientific Corporation
| 收益状态 | +3.67% 已平仓 |
|---|---|
| 进场成交 | 2026-09-08 · 盘前首笔 · 09-08 20:31 北京 · @46.9763 |
| 离场成交 | 2026-09-09 · 常规开盘 · @45.105 |
| 毛收益 | +3.98% |
| 成本 | +0.31% |
| 净收益 | +3.67% |
| 计入收益 | +3.67% |
| 计入 | 同日重复,不计入曲线 |
| 建仓日 | 2026-09-08 · 进场不早于新闻时刻 + 2 分钟 |
收益口径 event_time_plus_2min_10min_walk_open_topup_to_next_open_exchange_calendar_fill_model_local_notional_v9 · method_id m8db1cbc8f2d · 截至 2026-10-27 13:51
研究档案
结论摘要
本次社媒清单中多数为盘前个股异动摘要，最可执行的是Boston Scientific的8-K：公司确认网络攻击导致制造、订单和发货中断，并称三季度和全年指引大概率无法达成。该利空由SEC一手披露且美股盘中可成交；反面是公司称配送和多数制造已恢复、长期财务状况不受重大影响，因此只给小仓短线做空而非重仓趋势空。
消息传播链
- Boston Scientific的8-K被SEC接收，披露Item 1.05重大网络安全事件，构成本次业绩影响的首个一手锚点。市场反应:盘前报道显示BSX下跌约2%-4%。
- WSJ扩散公司将无法达到三季度和全年2026财务目标，并补充盘前跌约4%。市场反应:盘前跌至报道所称约45.90美元。
- ZeroHedge将BSX纳入盘前异动清单，说明该催化已进入交易员信息流。市场反应:清单称BSX盘前跌约2%。
关键理由
- SEC一手8-K将事件从运营扰动升级为三季度和全年业绩指引无法达成，属于明确负面预期重置。
- 原指引为三季度销售增长3%-5%、调整EPS 0.80-0.82美元，全年销售增长5.5%-6.5%、调整EPS 3.28-3.32美元；新增缺口尚未量化，但已覆盖全年口径。
- 美股当前处于连续交易时段，盘前跌幅约2%-4%尚未完全反映10月28日前业绩重估与诉讼/调查尾部风险。
主要风险
- 公司称主要配送中心已恢复至正常或以上水平、多数制造已恢复，若后续缺口主要为递延收入且可追回，做空空间会受限。
- 公司明确不预期长期财务状况受到重大影响，若盘中低开后买盘承接强，应快速降低或退出空头。
反向证据
- 做空前查反向 · 来源 web · 日期 2026-09-05 · 影响 weakens
公司称主要配送中心已恢复、制造多数恢复，产品功能未见超出既有LATITUDE激活中断的影响，削弱空头幅度。
检索:Boston Scientific cyberattack recovery update long-term financial condition no ongoing unauthorized access 原文 ↗ - 做空前查反向 · 来源 filing · 日期 2026-09-08 · 影响 weakens
8-K称不预期该事件对长期财务状况产生重大影响，说明交易应限于短线业绩重估。
检索:Boston Scientific 8-K long-term financial condition cyber incident 2026 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例确认方向但限制仓位和持有期，采用小仓SHORT_NOW并设置较紧止损。
方向:相似网络攻击运营中断案例支持短线负向，但行业与时点锚不够对齐。
涨幅量级:缺少8分以上同市场同机制医疗器械先例，不能用先例给出大幅目标，只能支持小仓短空。
形态:先例没有稳定的首日见光死结论，更多是财务量化前后持续重估。
历史先例(按相似度)
- 相似度 6/10 MGM 2023-09-11 MGM 2023年网络攻击造成系统关闭和运营受扰，之后披露三季度EBITDAR受约1亿美元影响。 原文 ↗
MGM披露后相对SPY首日约-3.0个百分点，7日约-7.8个百分点。
相似度依据:同为网络攻击导致经营中断并后续影响业绩，但行业不同且首发具体时刻不精确。
经验:网络攻击若真实扰乱运营，初跌后仍可能有数日到数周的相对弱势。 - 相似度 6/10 CLX 2023-08-14 Clorox在8-K披露未授权活动导致部分业务运营中断且调查处早期。 原文 ↗
CLX在后续网络攻击财务影响披露阶段持续承压。
相似度依据:同为上市公司披露网络攻击造成业务运营中断，但初始披露未同步给出全年指引无法达成。
经验:供应链和订单履约受阻的网络事件通常需要后续财务量化才完成重估。
工具执行结果 · 成功 3 · 降级 0 · 失败 0 · 取消 0
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
原文全文
展开原文 · 1,852 字
Premarket movers:
Mag 7 stocks are mostly lower: Nvidia +0.3%, Tesla +0.2%, Alphabet -0.7%, Apple -0.4%, Amazon -0.9%, Microsoft -0.8%, Meta Platforms -0.5%
Best Buy (BBY) slips 2% after DA Davidson cut the recommendation on the consumer electronics retailer to neutral, citing the stock’s valuation following a 35% year-to-date gain.
Bloom Energy (BE) rises 6% and Everpure (P) gains 2% after S&P Dow Jones Indices said the companies will join the S&P 500 Index.
Boston Scientific (BSX) slips 2% after the company said that the cyber attack that recently affected operations is likely to have a material impact on third quarter and fiscal 2026 results.
Herbalife (HLF) rises 7% after the maker of dietary supplements announced a $250 million share buyback.
Ionis Pharmaceuticals (IONS) falls 10% and Amgen (AMGN) slumps 5% after Novartis AG said its heart medication, pelacarsen, failed in a final-stage study.
Pharvaris (PHVS) soars 25% after a Phase 3 trial of its deucrictibant extended-release tablet for the prevention of hereditary angioedema attacks met its primary and secondary endpoints.
Rigetti Computing (RGTI) rises 5% after the quantum computing firm signed a $100 million pact with the US Department of Commerce to accelerate superconducting quantum computing R&D.
Roivant (ROIV) gains 20% after the drugmaker said a mid-stage study of its inhaled drug, mosliciguat, met its primary endpoint in the treatment for a lung disease.
Sigma Lithium (SGML) drops 16% after a Brazilian court ordered the suspension of all environmental permits for an operating subsidiary of the company and the complete halt of mining activities for the firm’s Grota do Cirilo lithium project.
Sweetgreen (SG) is up 5% after KeyBanc raised its recommendation on the salad restaurant chain to overweight, calling it a compelling turnaround opportunity.
Mag 7 stocks are mostly lower: Nvidia +0.3%, Tesla +0.2%, Alphabet -0.7%, Apple -0.4%, Amazon -0.9%, Microsoft -0.8%, Meta Platforms -0.5%
Best Buy (BBY) slips 2% after DA Davidson cut the recommendation on the consumer electronics retailer to neutral, citing the stock’s valuation following a 35% year-to-date gain.
Bloom Energy (BE) rises 6% and Everpure (P) gains 2% after S&P Dow Jones Indices said the companies will join the S&P 500 Index.
Boston Scientific (BSX) slips 2% after the company said that the cyber attack that recently affected operations is likely to have a material impact on third quarter and fiscal 2026 results.
Herbalife (HLF) rises 7% after the maker of dietary supplements announced a $250 million share buyback.
Ionis Pharmaceuticals (IONS) falls 10% and Amgen (AMGN) slumps 5% after Novartis AG said its heart medication, pelacarsen, failed in a final-stage study.
Pharvaris (PHVS) soars 25% after a Phase 3 trial of its deucrictibant extended-release tablet for the prevention of hereditary angioedema attacks met its primary and secondary endpoints.
Rigetti Computing (RGTI) rises 5% after the quantum computing firm signed a $100 million pact with the US Department of Commerce to accelerate superconducting quantum computing R&D.
Roivant (ROIV) gains 20% after the drugmaker said a mid-stage study of its inhaled drug, mosliciguat, met its primary endpoint in the treatment for a lung disease.
Sigma Lithium (SGML) drops 16% after a Brazilian court ordered the suspension of all environmental permits for an operating subsidiary of the company and the complete halt of mining activities for the firm’s Grota do Cirilo lithium project.
Sweetgreen (SG) is up 5% after KeyBanc raised its recommendation on the salad restaurant chain to overweight, calling it a compelling turnaround opportunity.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。